Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow Quality Index
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow Quality Index of 1.44x as of December 2025. Operating cash flow of CN¥106.82 Million exceeds net income of CN¥74.10 Million, indicating high earnings quality where cash backs reported profits. Explore 600976 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jianmin Pharmaceutical Group Co Ltd Cash Flow Quality Index (2003–2025)
Historical Cash Flow Quality Index for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600976 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year earnings quality comparison for Jianmin Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see 600976 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.76x | CN¥274.53 Million | CN¥359.84 Million | ▲ +17.9% |
| 2024 | 0.65x | CN¥234.27 Million | CN¥362.18 Million | ▲ +26.1% |
| 2023 | 0.51x | CN¥268.39 Million | CN¥523.23 Million | ▼ -3.6% |
| 2022 | 0.53x | CN¥215.87 Million | CN¥405.50 Million | ▼ -33.2% |
| 2021 | 0.80x | CN¥259.18 Million | CN¥325.42 Million | ▼ -5.7% |
| 2020 | 0.84x | CN¥125.54 Million | CN¥148.69 Million | ▲ +5.1% |
| 2019 | 0.80x | CN¥74.45 Million | CN¥92.63 Million | ▲ +2.7% |
| 2018 | 0.78x | CN¥63.60 Million | CN¥81.30 Million | ▲ +103.2% |
| 2017 | 0.38x | CN¥35.20 Million | CN¥91.44 Million | ▼ -78.0% |
| 2016 | 1.75x | CN¥113.84 Million | CN¥65.06 Million | ▲ +214.2% |
| 2015 | 0.56x | CN¥48.45 Million | CN¥87.00 Million | ▼ -35.8% |
| 2014 | 0.87x | CN¥103.23 Million | CN¥118.95 Million | ▲ +84.1% |
| 2013 | 0.47x | CN¥45.36 Million | CN¥96.20 Million | ▼ -60.4% |
| 2012 | 1.19x | CN¥98.17 Million | CN¥82.54 Million | ▲ +223.3% |
| 2011 | -0.97x | CN¥-75.54 Million | CN¥78.28 Million | ▼ -144.0% |
| 2010 | 2.19x | CN¥150.08 Million | CN¥68.50 Million | ▲ +52.5% |
| 2009 | 1.44x | CN¥66.69 Million | CN¥46.42 Million | ▼ -79.7% |
| 2008 | 7.08x | CN¥110.11 Million | CN¥15.55 Million | ▲ +1002.6% |
| 2007 | -0.78x | CN¥-6.88 Million | CN¥8.77 Million | ▼ -118.9% |
| 2006 | 4.15x | CN¥56.18 Million | CN¥13.55 Million | ▲ +394.8% |
| 2005 | -1.41x | CN¥-34.63 Million | CN¥24.62 Million | ▼ -1161.9% |
| 2004 | 0.13x | CN¥4.13 Million | CN¥31.20 Million | ▼ -10.3% |
| 2003 | 0.15x | CN¥4.19 Million | CN¥28.35 Million | — |